{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:30:17Z","timestamp":1782304217459,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijrobp.2012.01.035","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T08:15:36Z","timestamp":1333613736000},"page":"655-660","source":"Crossref","is-referenced-by-count":52,"title":["Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme"],"prefix":"10.1016","volume":"84","clinical-trial-number":[{"clinical-trial-number":"nct00792012","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Krishna","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Damek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie E.","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Ney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Waziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lillehei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Stuhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2012.01.035_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant TMZ versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","article-title":"Assumptions in the radiotherapy of glioblastoma","volume":"30","author":"Hochberg","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ijrobp.2010.07.021","article-title":"Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme","volume":"81","author":"Chen","year":"2011","journal-title":"Int J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0360-3016(97)00911-5","article-title":"High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme","volume":"40","author":"Nakagawa","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.20.6.1635","article-title":"Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy","volume":"20","author":"Chan","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation\u00a0therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-008-9689-z","article-title":"Hypofractionated radiotherapy\u00a0followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma","volume":"91","author":"Minniti","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0360-3016(03)00819-8","article-title":"The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial","volume":"58","author":"Sultanem","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0360-3016(03)01623-7","article-title":"Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme","volume":"58","author":"Floyd","year":"2004","journal-title":"Int J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ijrobp.2005.12.005","article-title":"Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT","volume":"64","author":"Iuchi","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2005.12.002","article-title":"Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy","volume":"65","author":"Ruben","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijrobp.2010.04.069","article-title":"Favorable prognosis in patients with high-grade glioma with radiation necrosis: The University of Colorado reoperation series","volume":"81","author":"Rusthoven","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3171\/jns.1999.91.2.0251","article-title":"Accelerated fractionated proton\/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: Results of a phase II prospective trial","volume":"91","author":"Fitzek","year":"1999","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2008.11.003","article-title":"Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis?","volume":"111","author":"Peca","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrclinonc.2009.150","article-title":"New advances that enable identification of glioblastoma recurrence","volume":"6","author":"Yang","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-009-9801-z","article-title":"Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis","volume":"94","author":"Torcuator","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","article-title":"Effect of bevacizumab on radiation necrosis of the brain","volume":"67","author":"Gonzalez","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.01.035_bib19","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2007.12.2440","article-title":"Bevacizumab plus irinotecan in recurrent glioblastoma multiforme","volume":"25","author":"Vredenburgh","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161200079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161200079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T03:30:55Z","timestamp":1543030255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161200079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S036030161200079X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.035","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}